Lipid Profile Improvement in Virologically Suppressed HIV-1-infected Patients Switched to Dolutegravir/Abacavir/Lamivudine: Data From the SCOLTA Project
Infection and Drug Resistance - New Zealand
doi 10.2147/idr.s203813
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2019
Authors
Publisher
Informa UK Limited